周四盘中，PROCEPT BioRobotics（股票代码：PRCT）股价大幅下挫8.08%，主要受多家华尔街分析师下调目标价的影响。
据报道，杰富瑞将PROCEPT BioRobotics的目标价从60美元大幅下调至51美元，Leerink Partners将目标价从90美元下调至83美元。此外，Truist Securities将目标价从70美元下调至64美元，而富国银行则将目标价从75美元大幅下调至58美元。
分析师普遍下调目标价反映出他们对PROCEPT BioRobotics未来增长前景的担忧。例如富国银行将目标价下调17美元，幅度之大表明分析师可能预见该公司面临重大阻力。这种悲观情绪迅速传导至市场，导致投资者在盘中交易中抛售该公司股票。目前尚不清楚是否有其他具体因素影响公司基本面，但多家机构不约而同下调目标价无疑给PROCEPT BioRobotics股价带来了巨大压力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.